These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33679744)

  • 1. JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS.
    Chen L; Zhong X; Cao W; Mao M; Li W; Yang H; Li M; Shi M; Zhang Y; Deng Y; Zu X; Liu J
    Front Immunol; 2021; 12():609319. PubMed ID: 33679744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRD4 suppression alleviates cerebral ischemia-induced brain injury by blocking glial activation via the inhibition of inflammatory response and pyroptosis.
    Zhou Y; Gu Y; Liu J
    Biochem Biophys Res Commun; 2019 Nov; 519(3):481-488. PubMed ID: 31530390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD4 Inhibition Attenuates Inflammatory Pain by Ameliorating NLRP3 Inflammasome-Induced Pyroptosis.
    Hua T; Wang H; Fan X; An N; Li J; Song H; Kong E; Li Y; Yuan H
    Front Immunol; 2022; 13():837977. PubMed ID: 35154163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis.
    Hao K; Jiang W; Zhou M; Li H; Chen Y; Jiang F; Hu Q
    Int J Biol Sci; 2020; 16(16):3163-3173. PubMed ID: 33162822
    [No Abstract]   [Full Text] [Related]  

  • 5. JQ1 attenuates neuroinflammation by inhibiting the inflammasome-dependent canonical pyroptosis pathway in SAE.
    Zhong X; Chen Z; Wang Y; Mao M; Deng Y; Shi M; Xu Y; Chen L; Cao W
    Brain Res Bull; 2022 Oct; 189():174-183. PubMed ID: 36100190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of BRD4 mitigates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium-infected macrophages by repressing endoplasmic reticulum stress.
    Wang QY; Yu XF; Ji WL
    Tuberculosis (Edinb); 2024 Sep; 148():102542. PubMed ID: 39024987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries.
    Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW
    EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRD4 inhibitor JQ1 protects against chronic obstructive pulmonary disease in mice by suppressing NF-κB activation.
    Liu Y; Huang ZZ; Min L; Li ZF; Chen K
    Histol Histopathol; 2021 Jan; 36(1):101-112. PubMed ID: 33215396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of BRD4 prevents proliferation and epithelial-mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis.
    Tan YF; Wang M; Chen ZY; Wang L; Liu XH
    Cell Death Dis; 2020 Apr; 11(4):239. PubMed ID: 32303673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
    Khan YM; Kirkham P; Barnes PJ; Adcock IM
    PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
    Suarez-Alvarez B; Morgado-Pascual JL; Rayego-Mateos S; Rodriguez RM; Rodrigues-Diez R; Cannata-Ortiz P; Sanz AB; Egido J; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
    J Am Soc Nephrol; 2017 Feb; 28(2):504-519. PubMed ID: 27436852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.
    Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X
    Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodomain-containing protein 4 inhibition alleviates matrix degradation by enhancing autophagy and suppressing NLRP3 inflammasome activity in NP cells.
    Hong J; Li S; Markova DZ; Liang A; Kepler CK; Huang Y; Zhou J; Yan J; Chen W; Huang D; Xu K; Ye W
    J Cell Physiol; 2020 Jul; 235(7-8):5736-5749. PubMed ID: 31975410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRD4 inhibition attenuates inflammatory response in microglia and facilitates recovery after spinal cord injury in rats.
    Wang J; Chen J; Jin H; Lin D; Chen Y; Chen X; Wang B; Hu S; Wu Y; Wu Y; Zhou Y; Tian N; Gao W; Wang X; Zhang X
    J Cell Mol Med; 2019 May; 23(5):3214-3223. PubMed ID: 30809946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1.
    Stewart HJ; Horne GA; Bastow S; Chevassut TJ
    Cancer Med; 2013 Dec; 2(6):826-35. PubMed ID: 24403256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression.
    Zhou B; Mu J; Gong Y; Lu C; Zhao Y; He T; Qin Z
    Redox Biol; 2017 Apr; 11():390-402. PubMed ID: 28063381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis.
    Lee MB; Lee JH; Hong SH; You JS; Nam ST; Kim HW; Park YH; Lee D; Min KY; Park YM; Kim YM; Kim HS; Choi WS
    BMB Rep; 2017 Dec; 50(12):640-646. PubMed ID: 29187284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo.
    Mu J; Zhang D; Tian Y; Xie Z; Zou MH
    J Mol Cell Cardiol; 2020 Dec; 149():1-14. PubMed ID: 32941882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis.
    Zhang QG; Qian J; Zhu YC
    Immunol Lett; 2015 Aug; 166(2):103-8. PubMed ID: 26093279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
    Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
    Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.